NCT04161027View on ClinicalTrials.gov

RCT for Pregabalin in Restless Legs Syndrome in South Korea

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2022

Conditions
Restless Legs Syndrome
Interventions
DRUG

Pregabalin 75mg

Pregabalin 75 mg capsule

DRUG

Placebos

Placebo capsule

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04161027 - RCT for Pregabalin in Restless Legs Syndrome in South Korea | Biotech Hunter | Biotech Hunter